AcelRx Pharma (ACRX) Misses Q1 EPS by 4c

AcelRx Pharma (NASDAQ: ACRX) reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $1.62 million.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c